The human Müllerian inhibiting substance type II receptor as immunotherapy target for ovarian cancer
暂无分享，去创建一个
C. Bascoul-Mollevi | H. Vié | I. Navarro-Teulon | F. Bibeau | A. Pèlegrin | M. Busson | V. Garambois | J. Pouget | Christian K. Behrens | T. Chardès | Imed Salhi | B. Clémenceau | C. Behrens | N. Kersual | Pauline Estupina